Peretz T - Search Results

1

Transcutaneous immunization with hydrophilic recombinant gp100 protein induces antigen-specific cellular immune response.

Eisenberg G, Machlenkin A, Frankenburg S, Mansura A, Pitcovski J, Yefenof E, Peretz T, Lotem M. Eisenberg G, et al. Among authors: peretz t. Cell Immunol. 2010;266(1):98-103. doi: 10.1016/j.cellimm.2010.09.003. Epub 2010 Sep 18. Cell Immunol. 2010. PMID: 20947070 Free PMC article.

2

[Active specific immunotherapy of malignant melanoma].

Lotem M, Shiloni E, Ingber A, Peretz T. Lotem M, et al. Among authors: peretz t. Harefuah. 1997 Aug;133(3-4):122-6. Harefuah. 1997. PMID: 9332080 Review. Hebrew. No abstract available.

3

Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin.

Lotem M, Hubert A, Lyass O, Goldenhersh MA, Ingber A, Peretz T, Gabizon A. Lotem M, et al. Among authors: peretz t. Arch Dermatol. 2000 Dec;136(12):1475-80. doi: 10.1001/archderm.136.12.1475. Arch Dermatol. 2000. PMID: 11115157 Clinical Trial.

4

Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV). The new American Joint Committee on Cancer.

Lotem M, Peretz T, Drize O, Gimmon Z, Ad El D, Weitzen R, Goldberg H, Ben David I, Prus D, Hamburger T, Shiloni E. Lotem M, et al. Among authors: peretz t. Br J Cancer. 2002 May 20;86(10):1534-9. doi: 10.1038/sj.bjc.6600251. Br J Cancer. 2002. PMID: 12085200 Free PMC article. Clinical Trial.

5

Mucosal melanoma of the female genital tract is a multifocal disorder.

Lotem M, Anteby S, Peretz T, Ingber A, Avinoach I, Prus D. Lotem M, et al. Among authors: peretz t. Gynecol Oncol. 2003 Jan;88(1):45-50. doi: 10.1006/gyno.2002.6848. Gynecol Oncol. 2003. PMID: 12504626

6

Cytogenetic analysis of melanoma cell lines: subclone selection in long-term melanoma cell cultures.

Lotem M, Yehuda-Gafni O, Butnaryu E, Drize O, Peretz T, Abeliovich D. Lotem M, et al. Among authors: peretz t. Cancer Genet Cytogenet. 2003 Apr 15;142(2):87-91. doi: 10.1016/s0165-4608(02)00798-7. Cancer Genet Cytogenet. 2003. PMID: 12699882

7

Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma.

Nachmias B, Ashhab Y, Bucholtz V, Drize O, Kadouri L, Lotem M, Peretz T, Mandelboim O, Ben-Yehuda D. Nachmias B, et al. Among authors: peretz t. Cancer Res. 2003 Oct 1;63(19):6340-9. Cancer Res. 2003. PMID: 14559822

8

Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma.

Lotem M, Shiloni E, Pappo I, Drize O, Hamburger T, Weitzen R, Isacson R, Kaduri L, Merims S, Frankenburg S, Peretz T. Lotem M, et al. Among authors: peretz t. Br J Cancer. 2004 Feb 23;90(4):773-80. doi: 10.1038/sj.bjc.6601563. Br J Cancer. 2004. PMID: 14970852 Free PMC article. Clinical Trial.

9

Production and purification of melanoma gp100 antigen and polyclonal antibodies.

Gelbart Y, Frankenburg S, Pinchasov Y, Krispel S, Eliahu D, Drize O, Morag E, Bartfeld D, Lotem M, Peretz T, Pitcovski J. Gelbart Y, et al. Among authors: peretz t. Protein Expr Purif. 2004 Apr;34(2):183-9. doi: 10.1016/j.pep.2003.12.006. Protein Expr Purif. 2004. PMID: 15003249

10

Recombinant hydrophilic human gp100: uptake by dendritic cells and stimulation of autologous CD8+ lymphocytes from melanoma patients.

Frankenburg S, Elias O, Gelbart Y, Drize O, Lotem M, Ingber A, Peretz T, Pitcovski J. Frankenburg S, et al. Among authors: peretz t. Immunol Lett. 2004 Jul 15;94(3):253-9. doi: 10.1016/j.imlet.2004.05.014. Immunol Lett. 2004. PMID: 15275974

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters